Viking Therapeutics (VKTX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Viking Therapeutics (VKTX) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Viking Therapeutics

· VKTX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

4.045 B

+2.48%

General

Market Cap: $4.05B
Enterprise Value: $3.68B
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -102.47%
ROE: -94.56%
ROIC: -135.79%
Current Ratio: 4.72
Debt-to-Equity: 0.01
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 9.31
EV/EBITDA: -6.89

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $560.02M
Operating Income: -$560.02M
Net Profit: -$534.8M

Balance Sheet

Cash and Equivalents: $125.75M
Working Capital: $407.91M
Total Assets: $521.9M
Net Debt: -$121.66M
Total Liabilities: $113.58M
Total Equity: $408.32M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$418.44M
Cash Flow from Investing: $399.26M
Cash Flow from Financing: $111.25M
Free Cash Flow: -$418.44M
Capital Expenditures: $0